SCHEMBL34475367

SCHEMBL34475367

Cn1cnc2c(OCc3ccccc3)cc(O)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RHEB Q15382 1/20 0.42
LIPE Q05469 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SRD5A2 P31213 2/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
SRD5A1 P18405 1/20 0.40
STAT3 P40763 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
BRD4 O60885 2/20 0.39
FFAR4 Q5NUL3 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAOB P27338 2/20 0.39
MPO P05164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34475846 0.85 MAOB (0.43) RHEBMAPTMAPK1TDP1L3MBTL1
SCHEMBL34475670 0.83 L3MBTL1 (0.49) LIPEMAPTTDP1L3MBTL1NPC1
SCHEMBL34474997 0.77 MAPT (0.42) MAPTL3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL34476471 0.76 PDE4B (0.36) MAPK1ALDH1A1MPOSLC6A2SLC6A3
SCHEMBL16437312 0.73 DAPK1 (0.43) RHEBL3MBTL1MEN1NPC1RAB9A
SCHEMBL21014675 0.72 DPP4 (0.36) MAPTMAPK1TDP1L3MBTL1SMN1; SMN2
SCHEMBL14283740 0.71 CYP2C19 (0.53) LIPEMAPTMAPK1TDP1L3MBTL1
SCHEMBL31068638 0.71 HTT (0.55) RHEBMAPTMAPK1TDP1L3MBTL1
SCHEMBL2090373 0.70 LMNA (0.52) LIPEMAPTMAPK1TDP1L3MBTL1
SCHEMBL31068640 0.68 GABRP (0.44) RHEBMAPTMAPK1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087650-A1 VINYLOXY-ARYL COMPOUNDS FOR THE TREATMENT OF CANCER SANOFI (FR) 2026-04-30 WO disclosed